Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Blake P., Lewis J. A. Epanolol as a model for assessing patient preference in anti-anginal drug therapy. J Clin Pharmacol. 1992 Jan;32(1):85–90. doi: 10.1002/j.1552-4604.1992.tb03793.x. [DOI] [PubMed] [Google Scholar]
- France L. A., Lewis J. A., Kay R. The analysis of failure time data in crossover studies. Stat Med. 1991 Jul;10(7):1099–1113. doi: 10.1002/sim.4780100710. [DOI] [PubMed] [Google Scholar]
- Gail M. H. Eligibility exclusions, losses to follow-up, removal of randomized patients, and uncounted events in cancer clinical trials. Cancer Treat Rep. 1985 Oct;69(10):1107–1113. [PubMed] [Google Scholar]
- Gould A. L. A new approach to the analysis of clinical drug trials with withdrawals. Biometrics. 1980 Dec;36(4):721–727. [PubMed] [Google Scholar]
- Lewis J. A. Statistical standards for protocols and protocol deviations. Recent Results Cancer Res. 1988;111:27–33. doi: 10.1007/978-3-642-83419-6_4. [DOI] [PubMed] [Google Scholar]
- Murray G. D., Findlay J. G. Correcting for the bias caused by drop-outs in hypertension trials. Stat Med. 1988 Sep;7(9):941–946. doi: 10.1002/sim.4780070905. [DOI] [PubMed] [Google Scholar]
- Peto R., Pike M. C., Armitage P., Breslow N. E., Cox D. R., Howard S. V., Mantel N., McPherson K., Peto J., Smith P. G. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design. Br J Cancer. 1976 Dec;34(6):585–612. doi: 10.1038/bjc.1976.220. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Peto R., Pike M. C., Armitage P., Breslow N. E., Cox D. R., Howard S. V., Mantel N., McPherson K., Peto J., Smith P. G. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. Br J Cancer. 1977 Jan;35(1):1–39. doi: 10.1038/bjc.1977.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Temple R., Pledger G. W. The FDA's critique of the anturane reinfarction trial. N Engl J Med. 1980 Dec 18;303(25):1488–1492. doi: 10.1056/NEJM198012183032534. [DOI] [PubMed] [Google Scholar]